Publications by authors named "J O Almquist"

Claim this Profile
A
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.
Anna Lundahl, Rod Hughes, Joachim Almquist, David Close, Jukka Mäenpää

Br J Clin Pharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055.
Xiao-Hong Zhou, Susanne Prothon, Engin Liathdale, Nicola Ferrari, Kebria Hezaveh, Joachim Almquist

iScience· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial.
Philip Ambery, Grzegorz Zajac, Joachim Almquist, Susanne Prothon, Carol Astbury

Br J Clin Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety study.
Jacob M van Laar, Alejhandra Lei, Mary Safy-Khan, Joachim Almquist, Graham Belfield

Clin Transl Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab.
Weifeng Tang, Raj Tummala, Joachim Almquist, Michael Hwang, Wendy I White

Clin Pharmacokinet· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis